Fundraising FoxBirk Venture — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Accession Therapeuticsaccessiontherapeutics.cominApr 2024
Accession Therapeutics develops cancer treatments by harnessing immune system mechanisms, with a focus on T cell receptor therapies and engineered cell therapies.
BiotechHealthtechMedical Devices
Alan Parker(CSO and Founder of Trocept)inBent Jakobsen(CEO and Founder)in
Co-investorsiGlobe Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.